Stephen M Massa

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 8

Top Venues

Nature medicine

The Journal of neuroscience : the official journal of the Society for Neuroscience

Acta neuropathologica communications

University of Rochester School of Medicine and Dentistry (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Rochester School of Medicine and Dentistry

United States

PHD :: Pharmacology

Publications

Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine (2024)
Tao Yang, Harry Liu, Kevin C Tran, Albert Leng, Stephen M Massa, Frank M Longo
Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice. Acta neuropathologica communications 8 (1) (2020)
Emmanuel Darcq, Nadege Morisot, Khanhky Phamluong, Vincent Warnault, Jerome Jeanblanc, Frank M Longo, Stephen M Massa, Dorit Ron
The Neurotrophic Factor Receptor p75 in the Rat Dorsolateral Striatum Drives Excessive Alcohol Drinking. The Journal of neuroscience : the official journal of the Society for Neuroscience 36 (39) (2016)

Stephen M Massa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stephen M Massa